Nachrichten zur CRISPR Therapeutics AG Aktie

DUBLIN, Jan. 25, 2023 /PRNewswire/ -- The "CRISPR Technology: Global Markets" report has been added to ResearchAndMarkets.coms offering. A $9.2…

Last year paved the way for a potential breakthrough this year for both gene-editing biotech companies....…

Should investors buy this risky biotech stock as the company moves toward bringing its first major treatment to market?...…

In the latest trading session, CRISPR Therapeutics AG (CRSP) closed at $49.94, marking a +0.56% move from the previous day....…

These two companies are in very different situations but could generate significant returns for investors....…

CRISPR Therapeutics AG (CRSP) closed the most recent trading day at $46.68, moving -1.12% from the previous trading session....…